• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经鼻腔给药治疗神经紊乱的临床试验——批判性评价。

Clinical trials of intranasal delivery for treating neurological disorders--a critical review.

机构信息

Nanjing University School of Medicine, Jinling Hospital, Department of Neurology, 305 East Zhongshan Road, Nanjing 210002, Jiangsu Province, China.

出版信息

Expert Opin Drug Deliv. 2011 Dec;8(12):1681-90. doi: 10.1517/17425247.2011.633508.

DOI:10.1517/17425247.2011.633508
PMID:22097907
Abstract

INTRODUCTION

The intranasal delivery of therapeutics to the brain has achieved great success in preclinical studies. These findings are important because there are many neurological disorders without feasible treatments, due to a lack of effective drug delivery methods to the brain. Translating such intranasal delivery strategies from bench to bedside is an important step for curing these neurological diseases.

AREAS COVERED

This review summarizes recent clinical trials that have investigated the intranasal delivery of drugs to the brain to treat neurological disorders and their potential mechanisms of action. In addition, the potential opportunities as well as challenges of intranasal delivery in clinical trials are discussed.

EXPERT OPINION

The intranasal delivery of drugs to the brain is a novel method with great potential, and it may provide an extraordinary approach to overcome the existing barriers of drug delivery for treating some neurological disorders. Intranasal delivery of central nervous system therapeutics has shown promise in several clinical trials, which demonstrates both the need and importance of further research.

摘要

简介

将治疗药物经鼻腔递送至大脑在临床前研究中取得了巨大成功。这些发现非常重要,因为有许多神经疾病没有可行的治疗方法,这是由于缺乏有效的药物递送至大脑的方法。将此类鼻腔递药策略从实验室转化为临床应用是治疗这些神经疾病的重要步骤。

涵盖领域

本综述总结了最近的临床试验,这些临床试验研究了经鼻腔将药物递送至大脑以治疗神经疾病及其潜在的作用机制。此外,还讨论了鼻腔给药在临床试验中的潜在机遇和挑战。

专家意见

将药物经鼻腔递送至大脑是一种具有巨大潜力的新方法,它可能为克服某些神经疾病药物递送的现有障碍提供一种非凡的方法。几种临床前研究表明,中枢神经系统治疗药物的鼻腔给药具有良好的前景,这既表明了进一步研究的必要性,也凸显了其重要性。

相似文献

1
Clinical trials of intranasal delivery for treating neurological disorders--a critical review.经鼻腔给药治疗神经紊乱的临床试验——批判性评价。
Expert Opin Drug Deliv. 2011 Dec;8(12):1681-90. doi: 10.1517/17425247.2011.633508.
2
Intranasal delivery of stem cells to the brain.经鼻腔脑内递送干细胞。
Expert Opin Drug Deliv. 2011 May;8(5):623-32. doi: 10.1517/17425247.2011.566267. Epub 2011 Mar 19.
3
Intranasal delivery: circumventing the iron curtain to treat neurological disorders.鼻内给药:突破障碍治疗神经系统疾病。
Expert Opin Drug Deliv. 2015;12(11):1717-25. doi: 10.1517/17425247.2015.1065812. Epub 2015 Jul 24.
4
Insights into direct nose to brain delivery: current status and future perspective.直接鼻腔至脑递药的研究进展:现状与未来展望。
Drug Deliv. 2014 Mar;21(2):75-86. doi: 10.3109/10717544.2013.838713. Epub 2013 Oct 9.
5
Improved brain uptake of peptide-based CNS drugs via alternative routes of administrations of its nanocarrier delivery systems: a promising strategy for CNS targeting delivery of peptides.通过纳米载体递送系统的替代给药途径提高基于肽的中枢神经系统药物的脑摄取:一种用于肽的中枢神经系统靶向递送的有前景的策略。
Expert Opin Drug Metab Toxicol. 2014 Nov;10(11):1491-508. doi: 10.1517/17425255.2014.956080. Epub 2014 Sep 6.
6
Intranasal delivery of therapeutic proteins for neurological diseases.鼻腔内递呈治疗性蛋白用于神经疾病治疗。
Expert Opin Drug Deliv. 2011 Oct;8(10):1277-96. doi: 10.1517/17425247.2011.588204. Epub 2011 May 27.
7
Translational pharmacokinetics: challenges of an emerging approach to drug development in stroke.转化药代动力学:脑卒中药物研发新兴方法的挑战。
Expert Opin Drug Metab Toxicol. 2011 Jun;7(6):681-95. doi: 10.1517/17425255.2011.570259. Epub 2011 Apr 27.
8
Nanomaterial applications for neurological diseases and central nervous system injury.纳米材料在神经疾病和中枢神经系统损伤中的应用。
Prog Neurobiol. 2017 Oct;157:29-48. doi: 10.1016/j.pneurobio.2017.07.003. Epub 2017 Jul 22.
9
Novel central nervous system drug delivery systems.新型中枢神经系统药物传递系统。
Chem Biol Drug Des. 2014 May;83(5):507-20. doi: 10.1111/cbdd.12268. Epub 2014 Mar 14.
10
Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease.鼻内给药绕过血脑屏障,将治疗药物靶向输送至中枢神经系统,以治疗神经退行性疾病。
BMC Neurosci. 2008 Dec 10;9 Suppl 3(Suppl 3):S5. doi: 10.1186/1471-2202-9-S3-S5.

引用本文的文献

1
Attenuation of 6‑OHDA-Induced Neurotoxicity by 1,2,3-Triazole-Based Sulfonamides through SIRT1 Activity.基于1,2,3-三唑的磺酰胺通过SIRT1活性减轻6-羟基多巴胺诱导的神经毒性
ACS Omega. 2025 Jun 27;10(26):28296-28310. doi: 10.1021/acsomega.5c03278. eCollection 2025 Jul 8.
2
JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions.JAK-STAT信号通路在炎症和应激相关疾病中的作用:对治疗干预的启示
Mol Biomed. 2023 Nov 8;4(1):40. doi: 10.1186/s43556-023-00151-1.
3
Drug Delivery Challenges in Brain Disorders across the Blood-Brain Barrier: Novel Methods and Future Considerations for Improved Therapy.
跨越血脑屏障的脑部疾病中的药物递送挑战:改善治疗的新方法及未来考量
Biomedicines. 2021 Dec 4;9(12):1834. doi: 10.3390/biomedicines9121834.
4
Intranasal Orexin After Cardiac Arrest Leads to Increased Electroencephalographic Gamma Activity and Enhanced Neurologic Recovery in Rats.心脏骤停后经鼻给予食欲素可增加大鼠脑电图γ活动并促进神经功能恢复
Crit Care Explor. 2021 Feb 22;3(2):e0349. doi: 10.1097/CCE.0000000000000349. eCollection 2021 Feb.
5
Targeting Beclin1 as an Adjunctive Therapy against HIV Using Mannosylated Polyethylenimine Nanoparticles.使用甘露糖基化聚乙烯亚胺纳米颗粒将Beclin1作为抗HIV辅助疗法的靶点
Pharmaceutics. 2021 Feb 6;13(2):223. doi: 10.3390/pharmaceutics13020223.
6
Epilepsy Disease and Nose-to-Brain Delivery of Polymeric Nanoparticles: An Overview.癫痫疾病与聚合物纳米颗粒的鼻脑递送:概述
Pharmaceutics. 2019 Mar 13;11(3):118. doi: 10.3390/pharmaceutics11030118.
7
Emerging Roles of microRNAs in Ischemic Stroke: As Possible Therapeutic Agents.微小RNA在缺血性脑卒中中的新作用:作为潜在治疗药物
J Stroke. 2017 May;19(2):166-187. doi: 10.5853/jos.2016.01368. Epub 2017 May 8.
8
The effect of osteopontin and osteopontin-derived peptides on preterm brain injury.骨桥蛋白及骨桥蛋白衍生肽对早产脑损伤的影响。
J Neuroinflammation. 2014 Dec 3;11:197. doi: 10.1186/s12974-014-0197-0.
9
Cell based therapies for ischemic stroke: from basic science to bedside.缺血性中风的细胞疗法:从基础科学到临床应用
Prog Neurobiol. 2014 Apr;115:92-115. doi: 10.1016/j.pneurobio.2013.11.007. Epub 2013 Dec 12.
10
New innovations: therapeutic opportunities for intellectual disabilities.新的创新:智力障碍的治疗机会。
Ann Neurol. 2013 Sep;74(3):382-90. doi: 10.1002/ana.24002.